Christoph Martin Dehnhardt

USPTO Granted Patents = 51 (Patent Applications = 9)

CIPO Patents = 5 (Patent Applications = 4)

EPO Patents = 11 (Patent Applications = 22)

Average Co-Inventor Count = 10.4

ph-index = 9

Forward Citations = 325(Granted Patents)

Forward Citations (Not Self Cited) = 244(Dec 10, 2025)

Inventors with similar research interests:

Location History:

Cambridge, MA (US) (2013 - 2014)
New York, NY (US) (2008 - 2018)
Burnaby, CA (2015 - 2023)

Company Filing History:

25 out of 109

Xenon Pharmaceuticals Inc.

Wyeth Holdings Corporation

patents

where one patent can have more than one assignee

Years Active: 2008-2025

Loading Chart...

Areas of Expertise:

Bicyclic-Fused Heteroaryl Compounds

Heteroaryl-Substituted Sulfonamide Compounds

Benzenesulfonamide Compounds

Substituted Benzamides

Sodium Channel Blockers

IRAK4 Modulators

PI3 Kinase Inhibitors

mTOR Inhibitors

Triazine Compounds

Pyrazolopyridines

Indazoles

Therapeutic Agents

51 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12202836 - Bicyclic-fused heteroaryl or aryl compounds (2025-01-21),

2. 11702424 - Bicyclic-fused heteroaryl or aryl compounds (2023-07-18),

3. 11639351 - Heteroaryl-substituted sulfonamide compounds and their use as therapeutic agents (2023-05-02),

4. 11299490 - Benzenesulfonamide compounds and their use as therapeutic agents (2022-04-12),

5. 11203572 - Substituted benzamides and methods of use thereof (2021-12-21),

6. 11174268 - Benzenesulfonamide compouds and their use as therapeutic agents (2021-11-16),

7. 11149002 - Therapeutic compounds and methods of use thereof (2021-10-19),

8. 10981905 - Heteroaryl-substituted sulfonamide compounds and their use as therapeutic agents (2021-04-20),

9. 10899732 - Substituted benzamides useful as sodium channel blockers (2021-01-26),

10. 10815229 - Benzenesulfonamide compounds and their use as therapeutic agents (2020-10-27),

11. 10793579 - Bicyclic-fused heteroaryl or aryl compounds (2020-10-06),

12. 10787446 - Therapeutic compounds and methods of use thereof (2020-09-29),

13. 10766858 - Substituted benzamides and methods of use thereof (2020-09-08),

14. 10752623 - Heteroaryl-substituted sulfonamide compounds and their use as sodium channel inhibitors (2020-08-25),

15. 10662184 - Benzenesulfonamide compounds and their use as therapeutic agents (2020-05-26),

Title: Christoph Martin Dehnhardt - Innovator from Burnaby, CA

Introduction: Christoph Martin Dehnhardt is a renowned inventor hailing from Burnaby, Canada. His innovative spirit and dedication to creating groundbreaking solutions have earned him recognition in the field of technology and beyond.

Latest Patents: Christoph Martin Dehnhardt holds several patents in the areas of renewable energy technologies, sustainable materials, and advanced electronics. His recent patents focus on enhancing energy efficiency in urban environments and reducing carbon footprint.

Career Highlights: With a background in engineering and a passion for sustainability, Dehnhardt has led numerous projects that have revolutionized the way we approach environmental challenges. His career highlights include developing cutting-edge solar panel designs and implementing smart grid systems for efficient energy distribution.

Collaborations: Dehnhardt has collaborated with leading research institutions, universities, and tech companies to bring his inventions to life. His partnerships have resulted in the successful implementation of innovative technologies that have a positive impact on the environment and society as a whole.

Conclusion: Christoph Martin Dehnhardt's contributions to the field of technology and sustainability have solidified his reputation as a visionary inventor. His relentless pursuit of innovation continues to inspire others to push the boundaries of what is possible in creating a more sustainable future.

This text is generated by artificial intelligence and may not be accurate.